Listen for Gliptin Patients Complaining of Severe Joint Pain

October 2015

New warnings from experts will spur questions about whether "gliptin" diabetes meds (Januvia, Onglyza, etc) cause joint pain.

This is stemming from reports of patients on gliptins who developed severe, and sometimes disabling, pain in their joints.

The theory is that gliptins MIGHT lead to an enhanced inflammatory response in the body...causing pain and possibly swelling.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Recalls Pull Recalled Meds Immediately
Diabetes Meds Apply a "Take With Plenty of Water"Auxiliary Label to Jardiance Rxs
COPD Dispense Breo Ellipta in its Original Packaging
Interactions Lookout for Patients on Clopidogrel Plus Repaglinide
Women's Health Be Aware of Addyi's Risks
Diabetes Meds Listen for Gliptin Patients Complaining of Severe Joint Pain
HIV & AIDS Watch for Supplements That can Derail HIV Therapy
Testosterone Look out for Men Getting More Than One Form of Testosterone
Contraceptives Help Women get the Contraceptive That's Right for Them
Cholesterol Watch for "QOD" Versus "QD" Abbreviations on Statin Rxs
Oral Health Watch for Antibiotic Rxs Prior to Dental Work
Substance Use Disorder Look out for Non-Controlled Meds That can be Abused
Anticoagulants Watch for Patients Skipping Refills on Their Blood Thinner Rxs